1-10 of 10
Tahir Latif
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A First-in-Human Phase 1 Trial of NX-2127, a First-in-Class Bruton's Tyrosine Kinase (BTK) Dual-Targeted Protein Degrader with Immunomodulatory Activity, in Patients with Relapsed/Refractory B Cell Malignancies

Alexey Danilov, Michael T. Tees, Krish Patel, William G. Wierda, Manish Patel, Ian W. Flinn, Tahir Latif, Weiyun Ai, Meghan C. Thompson, Michael L. Wang, Clare Sun, Deborah M. Stephens, Michael J Thirman, Melissa Gessner, Johannes Wolff, Amanda Schwab, May Tan, Daniel Chan, Erin Meredith, Adrian Wiestner
Journal: Blood
Blood (2023) 142 (Supplement 1): 4463.
https://doi.org/10.1182/blood-2023-179872
Published: 2023
Journal Articles

Multiple Doses of Cnty-101, an iPSC-Derived Allogeneic CD19 Targeting CAR-NK Product, Are Safe and Result in Tumor Microenvironment Changes Associated with Response: A Case Study

Indu Ramachandran, Sarah Rothman, Mariano Clausi, Kile Mcfadden, Brenda Salantes, Gloria Jih, Thomas Brigman, Sam Kelly, Matthew S Hall, Stephanie Yee, Iphigenia Koumenis, Poulomee Das, Jordan Briggs, Tori Braun, Ying Yuan, Elizabeth Devlin, Adrienne Farid, Nikolaus S. Trede, Tamara K. Moyo, Tahir Latif, Krish Patel
Journal: Blood
Blood (2023) 142 (Supplement 1): 1654.
https://doi.org/10.1182/blood-2023-182313
Published: 2023
Journal Articles

Rational Polypharmacological Targeting of FLT3, JAK2, ABL and ERK1 By Pluripotin Suppresses the Adaptive Resistance to FLT3 Inhibitors in AML

Mohammad Azhar, Zachary Kincaid, Meenu Kesarwani, Tahir Latif, Sekhu Ansari, William Seibel, Mohammad Azam
Journal: Blood
Blood (2022) 140 (Supplement 1): 3101–3102.
https://doi.org/10.1182/blood-2022-167484
Published: 2022
Journal Articles

Motixafortide (BL-8040) and G-CSF Versus Placebo and G-CSF to Mobilize Hematopoietic Stem Cells for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: The Genesis Trial

Zachary D. Crees, Keith E. Stockerl-Goldstein, Sarah Larson, Árpád Illés, Giuseppe Milone, Massimo Martino, Patrick Stiff, Douglas W. Sborov, Denise L. Pereira, Ivana N. Micallef, Gemma Moreno Jiménez, Gábor Mikala, Maria liz paciello Coronel, Udo Holtick, John W. Hiemenz, Muzaffar H. Qazilbash, Nancy M. Hardy, Tahir Latif, Irene García-Cadenas, Abi Vainstein, Ella Sorani, Irit Gliko-Kabir, Inbal Goldstein, Shaul Kadosh, John F. DiPersio
Journal: Blood
Blood (2021) 138 (Supplement 1): 475.
https://doi.org/10.1182/blood-2021-144296
Published: 2021
Journal Articles

Momelotinib Is a Highly Potent Inhibitor of FLT3-Mutant AML

Mohammad Azhar, Zachary Kincaid, Meenu Kesarwani, Mark Wunderlich, Tahir Latif, Daniel Starczynowski, Mohammad Azam
Journal: Blood
Blood (2021) 138 (Supplement 1): 206.
https://doi.org/10.1182/blood-2021-148822
Published: 2021
Journal Articles

Hematopoietic Cell Transplantation of Higher CD34+ Cell Doses and Specific CD34+ Subsets Mobilized with Motixafortide and/or G-CSF Is Associated with Rapid Engraftment - a Post-Hoc Analysis of the Genesis Trial

Zachary D. Crees, Keith E. Stockerl-Goldstein, Michael Retting, Sarah M Larson, Arpad Illes, Giuseppe Milone, Massimo Martino, Patrick Stiff, Douglas W. Sborov, Denise L. Pereira, Ivana N. Micallef, Gemma Moreno Jiménez, Gábor Mikala, Maria Liz Paciello Coronel, Udo Holtick, John W. Hiemenz, Muzaffar H. Qazilbash, Nancy M. Hardy, Tahir Latif, Irene García-Cadenas, Ella Sorani, Liron Shemesh-Darvish, Abi Vainstein, Shaul Kadosh, John F. DiPersio
Journal: Blood
Blood (2021) 138 (Supplement 1): 2849.
https://doi.org/10.1182/blood-2021-146783
Published: 2021
Journal Articles

Loss of DUSP1 Is Synthetic Lethal to JAK2 V617F

Meenu Kesarwani, Zachary Kincaid, BS, Tahir Latif, MD, Mohammad Azam, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 51.
https://doi.org/10.1182/blood-2018-99-115503
Published: 2018
Journal Articles

Correlation of Non-Coding RNA Expression with Response to Proteasome Inhibitors in Multiple Myeloma

Ehsan Malek, MD, Tahir Latif, MD, Anil Goud Jegga, DVM, MS, Sajjeev Jagannathan, MS, Nikhil Vad, PhD, Mohamed A.Y. Abdel Malek, MD, James J. Driscoll, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3415.
https://doi.org/10.1182/blood.V124.21.3415.3415
Published: 2014
Journal Articles

Secondary CNS Relapse in DLBCL in the Rituximab Era - an Analysis of Prospective Studies

Abhimanyu Ghose, MD, Harold Kunal Elias, MD, Gunjan Guha, MSc, PhD, Mahender Yellu, MD, Ria Kundu, MD, Tahir Latif, MD
Journal: Blood
Blood (2014) 124 (21): 1644.
https://doi.org/10.1182/blood.V124.21.1644.1644
Published: 2014
Journal Articles

Lack of Influence of Rituximab and CNS Directed Prophylactic Therapy on CNS Relapse in High-Risk Diffuse Large B Cell Lymphoma

Mahender Yellu, MD, Ehsan Malek, MD, Berry Thavalathil, Tahir Latif, MD
Journal: Blood
Blood (2014) 124 (21): 1711.
https://doi.org/10.1182/blood.V124.21.1711.1711
Published: 2014